Search research articles
Contact Us
Filters
Showing results (41-50 of 116) with videos related to
Page
of 12
Sort By:
The European Journal of Neuroscience
|
April 3, 2003
Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors
Anders I Persson, Thorleif Thorlin, Cecilia Bull, et al.
Neuroscience Letters
|
March 10, 2016
Associations between a locus downstream DRD1 gene and cerebrospinal fluid dopamine metabolite concentrations in psychosis
Dimitrios Andreou, Erik Söderman, Tomas Axelsson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 25, 2017
Genetic variation and epigenetic modification of the prodynorphin gene in peripheral blood cells in alcoholism
Claudio D'Addario, Klementy Shchetynsky, Mariangela Pucci, et al.
Molecules (Basel, Switzerland)
|
April 12, 2022
Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT<sub>1A</sub>) Receptors Heterodimerization and Cellular Effectors (Ca<sup>2+</sup>, ERK1/2 and p38) Activation
Vlad Radoi, Gerd Jakobsson, Vinko Palada, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 26, 2010
Ethanol and acetaldehyde exposure induces specific epigenetic modifications in the prodynorphin gene promoter in a human neuroblastoma cell line
Claudio D'Addario, Sofia Johansson, Sanzio Candeletti, et al.
European Journal of Medicinal Chemistry
|
August 23, 2003
A structure-activity study of nociceptin-(1-13)-peptide amide. Synthesis of analogues substituted in positions 0, 1, 3, 4 and 10
Irina Bobrova, Mila Vlaskovska, Lubomir Kasakov, et al.
Alcoholism, Clinical and Experimental Research
|
October 22, 2011
Ethanol alters opioid regulation of Ca(2+) influx through L-type Ca(2+) channels in PC12 cells
Donna L Gruol, Thomas E Nelson, Christine Hao, et al.
Frontiers in Aging Neuroscience
|
January 25, 2021
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer's Disease
Mari Aksnes, Ann Tiiman, Trine Holt Edwin, et al.
Behavioral and Brain Functions : BBF
|
July 31, 2014
Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis
Dimitrios Andreou, Erik Söderman, Tomas Axelsson, et al.
Journal of Alzheimer'S Disease : JAD
|
February 25, 2022
Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort
Mari Aksnes, Hans Christian D Aass, Ann Tiiman, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 116) with videos related to
Sort By:
Page
of 12
The European Journal of Neuroscience
|
April 3, 2003
Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors
Anders I Persson, Thorleif Thorlin, Cecilia Bull, et al.
Neuroscience Letters
|
March 10, 2016
Associations between a locus downstream DRD1 gene and cerebrospinal fluid dopamine metabolite concentrations in psychosis
Dimitrios Andreou, Erik Söderman, Tomas Axelsson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 25, 2017
Genetic variation and epigenetic modification of the prodynorphin gene in peripheral blood cells in alcoholism
Claudio D'Addario, Klementy Shchetynsky, Mariangela Pucci, et al.
Molecules (Basel, Switzerland)
|
April 12, 2022
Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT<sub>1A</sub>) Receptors Heterodimerization and Cellular Effectors (Ca<sup>2+</sup>, ERK1/2 and p38) Activation
Vlad Radoi, Gerd Jakobsson, Vinko Palada, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 26, 2010
Ethanol and acetaldehyde exposure induces specific epigenetic modifications in the prodynorphin gene promoter in a human neuroblastoma cell line
Claudio D'Addario, Sofia Johansson, Sanzio Candeletti, et al.
European Journal of Medicinal Chemistry
|
August 23, 2003
A structure-activity study of nociceptin-(1-13)-peptide amide. Synthesis of analogues substituted in positions 0, 1, 3, 4 and 10
Irina Bobrova, Mila Vlaskovska, Lubomir Kasakov, et al.
Alcoholism, Clinical and Experimental Research
|
October 22, 2011
Ethanol alters opioid regulation of Ca(2+) influx through L-type Ca(2+) channels in PC12 cells
Donna L Gruol, Thomas E Nelson, Christine Hao, et al.
Frontiers in Aging Neuroscience
|
January 25, 2021
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer's Disease
Mari Aksnes, Ann Tiiman, Trine Holt Edwin, et al.
Behavioral and Brain Functions : BBF
|
July 31, 2014
Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis
Dimitrios Andreou, Erik Söderman, Tomas Axelsson, et al.
Journal of Alzheimer'S Disease : JAD
|
February 25, 2022
Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort
Mari Aksnes, Hans Christian D Aass, Ann Tiiman, et al.
Page
of 12